Carlsbad Technology
Carlsbad Technology is a Carlsbad, California-based generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor serving wholesalers, managed care accounts, and retail pharmacies nationwide. Founded in 1990, it operates as part of Taiwan's YungShin Group with cGMP-compliant, VAWD-accredited facilities.
- Company typePrivate
- Founded1990
- HeadquartersCarlsbad, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Carlsbad Technology does
Carlsbad Technology, Inc. is a Carlsbad, California-headquartered generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor that has operated continuously since 1990. The company manufactures a portfolio of generic oral solid-dose drugs—including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine—and distributes through direct sales to wholesalers, distributors, managed care accounts, and retail pharmacies across all 50 U.S. states and Puerto Rico. Carlsbad Technology is a privately held subsidiary of the Taiwan-based YungShin Group, which the company cites as the source of a stated "bridge" between Asian and Americas pharmaceutical markets.
The company's technical footprint centers on a single California campus featuring an FDA-approved, cGMP-compliant manufacturing facility with state-of-the-art equipment controlling production from raw ingredient to finished product. Supporting infrastructure includes temperature- and air-controlled rack storage, a cGMP-compliant sampling booth, restricted quarantine areas for non-conforming materials and returned products, and a warehouse management system (WMS) for inventory and order fulfillment. Carlsbad Technology holds multiple regulatory credentials: cGMP validation achieved in 1998, FDA approval of its manufacturing facility, VAWD (Verified-Accredited Wholesale Distributors) accreditation from the National Association of Boards of Pharmacy recognized in 21 states, and NABD accreditation. Its first ANDA approval was for Diclofenac Sodium Delayed Release Tablets in 1998.
Carlsbad Technology operates three revenue streams: (1) branded-generic pharmaceutical product sales across multiple therapeutic categories, sold on a quote-based, non-publicly-disclosed pricing basis; (2) regulatory advisory services spanning ANDA/DMF submissions, OTC monograph applications, prescription-to-OTC switches, 510(k)/PMA/IDE medical device pathways, dietary supplement NDI/GRAS approvals, and pharmacovigilance; and (3) contract manufacturing, packaging, and warehousing services for third-party partners leveraging its cGMP facility and temperature-controlled logistics. The go-to-market relies on direct enterprise sales supported by website, trade publication, and industry-event presence. Regulatory advisory functions both as a discrete revenue line and as a capability that supports entry of partners' products into the U.S. market.
Carlsbad Technology firmographics
Firmographics- Name
- Carlsbad Technology
- Legal name
- Carlsbad Technology, Inc.
- Website
- https://carlsbadtech.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Carlsbad Technology is a Carlsbad, California-based generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor serving wholesalers, managed care accounts, and retail pharmacies nationwide. Founded in 1990, it operates as part of Taiwan's YungShin Group with cGMP-compliant, VAWD-accredited facilities.
- Ownership category
- akta.pro rank
Carlsbad Technology industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where Carlsbad Technology is headquartered
LocationHeadquarters
- HQ city
- Carlsbad
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Carlsbad Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Generic Pharmaceutical Product Sales: Manufacturing and selling generic pharmaceutical drugs including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in various dosages and packaging configurations.
- Regulatory Advisory Services: FDA consulting services including drug approval consultations, regulatory submissions, compliance support, and US agent services for pharmaceutical, diagnostic, biotech, and medical device companies.
- Contract Manufacturing: Contract manufacturing services for generic pharmaceuticals and OTC products with cGMP-compliant facilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Generic pharmaceutical products - quote-based pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Carlsbad Technology product offering
Product offeringCore offering
Carlsbad Technology manufactures, packages, and distributes a portfolio of generic pharmaceutical drugs (capsules and tablets such as Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine) from its cGMP-compliant, FDA-approved facility in Carlsbad, California. The company also offers contract manufacturing for generic and OTC products, VAWD-accredited wholesale distribution with temperature-controlled warehousing, and FDA regulatory advisory/consulting services covering ANDA submissions, OTC monographs, medical devices, and dietary supplements.
Product overview
Carlsbad Technology is a generic pharmaceutical company offering a comprehensive portfolio of generic drugs and pharmaceutical services. The core product is their Generic Pharmaceuticals line including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in various strengths and packaging sizes. The company operates FDA-approved, cGMP-compliant manufacturing facilities and provides regulatory advisory services spanning drug approval consulting, OTC drug advisory, medical device regulatory services, dietary/health supplement approval, and pharmaceutical packaging. Additional services include VAWD-accredited wholesale distribution, warehousing with temperature control and WMS systems, and sales/marketing across all 50 U.S. states and Puerto Rico. The company entered the U.S. generic pharmaceutical market in 1990, with their first ANDA approved in 1998 for Diclofenac Sodium Delayed Release Tablets.
Differentiator
Problem solved
Functional benefit
Products and services
- Generic Pharmaceuticals (capsules and tablets) A portfolio of generic pharmaceutical drugs including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in capsules and tablets across multiple therapeutic categories (anti-infectives, anti-inflammatories, cardiovascular, neurological).
- FDA Approved Contract Manufacturing Contract manufacturing services using a cGMP-compliant, FDA-approved California facility with state-of-the-art equipment for generic and OTC pharmaceutical production, with rigorous raw material inspection and quality control throughout the manufacturing cycle.
- FDA Drug Approval Consulting Consulting services for pharmaceutical, diagnostics, biotech, and medical device companies covering ANDA submissions, Drug Master File (DMF) submissions, FDA meeting support, cGMP compliance, and US agent services.
- FDA OTC Drug Approval Consulting Consulting for over-the-counter drug approval including OTC drug monograph applications, prescription-to-OTC switch applications, and Time and Extent Application (TEA) preparation for OTC Drug Monograph amendments.
- FDA Medical Devices Regulatory Advisory Regulatory advisory for medical devices covering 510(k) Premarket Notifications, Investigational New Drug Applications (INDs), Investigational Device Exemption Applications (IDEs), Premarket Approval Applications (PMAs), Biologic License Applications (BLA), and 513(g) Requests for Classification.
- FDA Dietary Supplement Approval Consulting Regulatory consulting for dietary supplements including New Dietary Ingredient (NDI) notifications, GRAS (Generally Recognized as Safe) supplement approvals, regulatory label services, and FDA compliance.
- FDA Health Supplement Approval Regulatory Advisory Regulatory advisory for health supplements including GMP compliance and audits, label review, cGMP compliance, clinical trials, NDI notifications, documentation, recall assistance, and quality systems.
- Generic Pharmaceutical Drug Packaging Drug packaging and repackaging services ensuring compliance with FDA guidelines for labeling, container closure, product identity, quality, purity, and contamination prevention, including child-resistant features.
- Warehousing & Distribution Temperature-controlled warehouse storage with cGMP-compliant sampling booth and quarantine area, utilizing a Warehouse Management System (WMS) for inventory tracking, order fulfillment, and pharmaceutical supply chain management, supporting ambient, hazardous, and refrigerated conditions.
- VAWD-Accredited Wholesale Distribution Verified-Accredited Wholesale Distributors (VAWD) certified wholesale distribution recognized by 21 U.S. states, ensuring compliance with state and federal laws for distributing prescription drugs from manufacturers to pharmacies.
- Pharmaceutical Sales & Marketing Sales and marketing of generic pharmaceuticals across all 50 U.S. states and Puerto Rico, with capability to partner with contract developers and manufacturers to market their products.
Quantifiable outcome
- cGMP validation achieved in 1998, demonstrating long-term compliance capability
- +2 more outcomes
Companies that use Carlsbad Technology
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles3 records
Carlsbad Technology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Carlsbad Technology partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- YungShin GroupcoreCarlsbad Technology, Inc. is part of the worldwide YungShin Group, which provides strength, commitment to innovation, and pursuit of providing the best medicines to enhance human health. YungShin represents world-class quality standards.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Carlsbad Technology competitors and assessment
Company assessmentBroad incumbents
- Dr. Reddy's Laboratories: India-headquartered global pharmaceutical company with a substantial U.S. generics business. Comparable in cross-border generics supply chain and FDA-approved manufacturing footprint, though materially larger and broader in API and finished dosage portfolio.
- Endo International: Specialty and generic pharmaceutical manufacturer with a portfolio spanning sterile injectables, generic solids, and branded specialty. A broader incumbent versus Carlsbad Tech, with overlapping generics distribution but a substantially wider therapeutic footprint.
- Sandoz: Novartis's generic pharmaceutical division with global manufacturing and U.S. distribution. A broad incumbent competing head-to-head with Carlsbad Tech across generic solid orals, injectables, and biosimilars, but at a vastly larger scale.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with extensive U.S. operations and a broad ANDA portfolio across most therapeutic categories. Comparable as a competitor in the same generic categories Carlsbad Tech serves, but at vastly greater scale and portfolio breadth.
Direct peers
- Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with a large U.S. subsidiary (Aurobindo Pharma USA) and FDA-approved manufacturing facilities. Comparable to Carlsbad Tech through its foreign-parent-backed U.S. generics distribution model and ANDA-heavy portfolio.
- Glenmark Pharmaceuticals: India-headquartered generic pharmaceutical company with a U.S. presence (Glenmark Pharmaceuticals Inc., USA). Comparable to Carlsbad Tech as a foreign-owned, U.S.-distributed generic manufacturer serving wholesalers and managed care accounts.
- Apotex: Canadian-headquartered generic pharmaceutical manufacturer with significant U.S. distribution and a broad ANDA portfolio. Comparable to Carlsbad Tech in generic manufacturing, FDA-approved facility profile, and cross-border supply chain orientation.
- Upsher-Smith Laboratories: Mid-sized U.S. generic pharmaceutical manufacturer with both branded specialty and generic product lines. Comparable to Carlsbad Tech in target customers, therapeutic categories (cardiovascular, CNS), and contract manufacturing/distribution capabilities.
- Lannett Company: U.S. generic drug manufacturer with a portfolio spanning solid oral, topical, and specialty generics. Comparable to Carlsbad Tech in business model (generic manufacturer/distributor) and competitive positioning as a smaller U.S. generics player.
- Amneal Pharmaceuticals: U.S.-focused generic and specialty pharmaceutical manufacturer with an integrated manufacturing and distribution model. Closely comparable to Carlsbad Tech in product mix, ANDA strategy, and mid-tier scale, but materially larger in headcount and portfolio breadth.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Carlsbad Technology social profiles
Digital presenceCarlsbad Technology compliance and trust
Trust signalCompliance3 records
Carlsbad Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Carlsbad Technology leadership team
Management profileNumber of profiles
Profiles1 record
Carlsbad Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Carlsbad Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Carlsbad Technology
What does Carlsbad Technology do?
Carlsbad Technology manufactures, packages, and distributes a portfolio of generic pharmaceutical drugs (capsules and tablets such as Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine) from its cGMP-compliant, FDA-approved facility in Carlsbad, California. The company also offers contract manufacturing for generic and OTC products, VAWD-accredited wholesale distribution with temperature-controlled warehousing, and FDA regulatory advisory/consulting services covering ANDA submissions, OTC monographs, medical devices, and dietary supplements.
Is Carlsbad Technology a public or private company?
Carlsbad Technology is a private company. It is classified as corporate owned and is currently operating.
When was Carlsbad Technology founded?
Carlsbad Technology was founded in 1990. It employs 51 to 100 people.
Where is Carlsbad Technology based?
Carlsbad Technology is headquartered in Carlsbad, United States, in the North America region.
How does Carlsbad Technology make money?
Three revenue lines are on record. Generic Pharmaceutical Product Sales are the primary driver. The others are regulatory Advisory Services and contract Manufacturing.
Who are Carlsbad Technology's main competitors?
Broad incumbents on record are Dr. Reddy's Laboratories, Endo International, Sandoz and Teva Pharmaceutical Industries. Direct peers are Aurobindo Pharma, Glenmark Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Lannett Company and Amneal Pharmaceuticals.
Does Carlsbad Technology have an API?
No public API is recorded for Carlsbad Technology.
What industry is Carlsbad Technology in?
Carlsbad Technology's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 424210 and its SIC code is 5122.